Novartis wins Jakavi green light in Europe; Zydus Cadila launches Indian Sovaldi copies;

@FiercePharma: ICYMI yesterday: All clear for Actavis to become Allergan as EU watchdogs approve $66B merger. Article | Follow @FiercePharma

@EricPFierce: DEA says it is not the cause of shortages of scheduled drugs, that it is just misunderstood. ICYMI from FiercePharmaManufacturing | Follow @EricPFierce

> A New York federal judge has granted early approval to a $400 million settlement ending a class action lawsuit accusing Pfizer ($PFE) of misleading investors about off-label marketing. Report (sub. req.)

> Novartis ($NVS) has won EU approval for Jakavi in polycythemia vera. Release

> Merck KGaA has placed a $4 billion bond with institutional investors to help fund its $17 billion acquisition of Sigma-Aldrich ($SIAL). Report

> Sanofi's ($SNY) Indian affiliate, Shantha Biotechnics, will provide up to 37 million doses of pediatric vaccine Shan5. Release

> India's Zydus Cadila has launched a generic version of Gilead's ($GILD) hepatitis C star Sovaldi in its home country under the brand name SoviHep. Report

Medical Device News

@FierceMedDev: Illumina hits U.K. company with prenatal test patent suit. FierceDiagnostics story | Follow @FierceMedDev

@VarunSaxena2: J&J hosts oral biologics startup at its new incubator to help it find Remicade's replacement. More from FierceDrugDelivery | Follow @VarunSaxena2

@EmilyWFierce: FDA warning on power morcellators triggers "broad transformation" in clinical practice. WSJ story (sub. req.) | Follow @EmilyWFierce

> Fast-spreading CRISPR tech inspires new preclinical work on blood cancers. Story

> Physicians opt out of morcellator procedures months after FDA warning. Report

> Medtronic backs diabetes device connectivity, analysis startup Glooko in $16.5M Series B. Article

Biotech News

@FierceBiotech: ICYMI yesterday: Department reorganizations at Biogen Idec raise fears of future cuts. Report | Follow @FierceBiotech

@JohnCFierce: $KITE sees its TCR work as a key distinguishing factor in an increasingly crowded field. Sets up Kite EU in $21M deal. Release | Follow @JohnCFierce

> Esperion's potential PCSK9 spoiler scores more positive data. News

> Galapagos registers another setback as J&J dumps anti-inflammatory pact. Story

> CAR-T player Kite Pharma buys its way into Europe and pads its anticancer arsenal. Article

> GlaxoSmithKline and J&J back a $100M new Alzheimer's R&D project. Report

Drug Delivery News

> Efforts at intracochlear drug delivery to treat hearing loss gaining momentum. Item

> Depomed picks up loan for second half of $1.05B Nucynta acquisition from J&J. More

> New optogenetics technique does away with genetic modification. Story

> Glide touts studies of its delivery system as it prepares to take on Novartis' Sandostatin. Item

> J&J hosts oral biologics startup at its new incubator to help it find Remicade's replacement. Article

Pharma Manufacturing News

> Malaysia's CCM Duopharma Biotech adds plants to compete better. More

> Actavis becomes Allergan and looks to manufacturing for cutting costs. Item

> WuXi to bulk up cell therapy manufacturing in Philadelphia. Article

> New York set to get another drug manufacturing project. Story

> Florida CDMO gets taxpayer boost for expansion, 100 jobs. Report

Pharma Asia News

> Astellas says stem cell research promising on kidney failure. Item

> India and U.S. scientists battle over virulence of swine flu strain in India. Report

> Big Three Asia pharma markets poised to soar in 2015, reports say. Story

> South Korea's Green Cross pushes into cell therapy manufacturing in China. More

> Doctor outreach at heart of Daiichi Sankyo $39 million Medicaid lawsuit settlement. Article

And Finally... "Gone Girl" actress Carrie Coon will star in the world premier of "Placebo," a play about a pharma researcher administering a trial for a new female arousal drug. More (sub. req.)